Related Experiment Video
Updated: Aug 12, 2026
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Immunotherapy of malignant melanoma
1Department of Surgery, University of California, San Francisco, USA.
The Surgical Clinics of North America
|December 1, 1996
Summary
Immunotherapy shows promise for malignant melanoma, inducing remissions in some patients. Further research is crucial to enhance effectiveness and explore its use in preventing recurrence after surgery.
Area of Science:
- Oncology
- Immunology
Background:
- Malignant melanoma immunotherapy and biologic therapy demonstrate promising preliminary results.
- Understanding immune responses to melanoma is key to developing targeted therapies.
Purpose of the Study:
- To review the current state and future directions of immunotherapy for malignant melanoma.
- To highlight the need for further research to improve response rates and explore adjuvant therapies.
Main Methods:
- Review of existing data on immunotherapy and biologic therapy for melanoma.
- Discussion of various immunotherapeutic approaches including INF-alpha, IL-2, LAK cells, TIL cells, and tumor vaccines.
- Exploration of combination therapies with chemotherapy and adjuvant treatment strategies.
Main Results:
- Complete and partial remissions observed in some patients with metastatic melanoma.
- Overall response rates currently around 20%, indicating a need for improved strategies.
- Combination therapy and adjuvant treatment show potential for preventing recurrence.
Conclusions:
- Immunotherapy holds significant potential for malignant melanoma treatment.
- Further research into immune mechanisms of tumor rejection is essential.
- Future strategies should focus on well-defined molecules, antigenic systems, and enhancing immune responses for broader application in solid tumors.
More Related Videos
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:30Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...